Purpose
To assess the technical success rate and diagnostic performance of liver MR elastography (MRE) in a retrospective study of clinical patients.
Materials and Methods
This retrospective study was IRB approved with informed consent. A total of 1377 consecutive MRE examinations in 1287 patients for clinical indications were included from 2007 to 2010. Medical records were used to retrieve MRE-assessed liver stiffness, histological analysis, blood work and other liver disease related information. Nonparametric Kruskal-Wallis tests and analysis of covariance methods were used to evaluate the diagnostic values and relationships of the collected data.
Results
Hepatic MRE had a success rate of 94.4% (1300/1377) and reproducible measurements (r=0.9716, p<0.0001) in our study cohort with a complex patient profile and multiple interpreters. Body mass index had no significant effect on the success rate (p=0.2). In 289 patients with liver biopsy performed within 1 year of the MRE exam date, MRE-assessed liver stiffness is significantly higher in advanced fibrosis stages (F3-4) than mild to moderate fibrosis stages (F0-1-2) (5.93±2.31 versus 3.35±1.44 kPa, p<0.0001). Liver stiffness is associated with many factors other than fibrosis extent, including etiology of fibrosis (viral hepatitis C versus nonalcoholic fatty liver disease, p=0.025), inflammation (severe versus mild to moderate, p=0.03), and hepatic metabolic and synthetic function (no versus intermediate fibrosis, p≤0.01).
Conclusion
In our general clinical practice environment, hepatic MRE is a very robust imaging method with a high success rate for a broad spectrum of patients. It also demonstrates the complex association between liver stiffness and hepatic pathophysiology.